Glenmark Pharmaceuticals
GLENMARK.NS
#2691
Rank
โ‚น437.72 B
Marketcap
โ‚น1,551
Share price
-1.65%
Change (1 day)
114.02%
Change (1 year)

EPS for Glenmark Pharmaceuticals (GLENMARK.NS)

EPS in 2023 (TTM): โ‚น9.02

According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is โ‚น9.27. In 2022 the company made an earnings per share (EPS) of โ‚น32.83 a decrease over its 2021 EPS that were of โ‚น41.14.

EPS history for Glenmark Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น9.02-72.53%
2022โ‚น32.83-20.18%
2021โ‚น41.147.13%
2020โ‚น38.4025.72%
2019โ‚น30.54-22.01%
2018โ‚น39.1630.15%
2017โ‚น30.09-34.82%
2016โ‚น46.1663.09%
2015โ‚น28.319.68%
2014โ‚น25.81-26.58%
2013โ‚น35.150.51%
2012โ‚น34.97